MedTrace Logo

Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure

NCT01687647 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2014-04-09

No results posted yet for this study

Summary

Workers exposed to asbestos are at high risk of lung cancer. Medical follow-up of this population relies on repeated CT-scans which are more accurate for detection of peripheral lesions, and expose to X-rays and to risk of false-positives. Analysis of sputum using automate cytometry may be of interest in this population, alone or in combination with CT-scan.

An ancillary study will evaluate the interest of blood predictive biomarkers.

Conditions

  • Lung Neoplasms

Interventions

OTHER

low-dose CT-scan AND induced sputum sample AND blood test

All subjects will receive a low-dose CT-scan, a blood test (ancillary study) and provide an induced sputum

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Lydia GUITTET, MD,PhD · Caen University Hospital, INSERM

Study Design

Allocation
NA
Purpose
SCREENING
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
56 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-03-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01687647 on ClinicalTrials.gov